Related references
Note: Only part of the references are listed.Pancreatic tumor cell metabolism: Focus on glycolysis and its connected metabolic pathways
Fabienne Guillaumond et al.
ARCHIVES OF BIOCHEMISTRY AND BIOPHYSICS (2014)
Randomized double-blinded, placebo-controlled phase II trial of simvastatin and gemcitabine in advanced pancreatic cancer patients
Jung Yong Hong et al.
CANCER CHEMOTHERAPY AND PHARMACOLOGY (2014)
Cholesteryl Ester Accumulation Induced by PTEN Loss and PI3K/AKT Activation Underlies Human Prostate Cancer Aggressiveness
Shuhua Yue et al.
CELL METABOLISM (2014)
Pancreatic Adenocarcinoma
David P. Ryan et al.
NEW ENGLAND JOURNAL OF MEDICINE (2014)
Oxysterols in cancer cell proliferation and death
Jan de Weille et al.
BIOCHEMICAL PHARMACOLOGY (2013)
Targeting the Ras-ERK pathway in pancreatic adenocarcinoma
Cindy Neuzillet et al.
CANCER AND METASTASIS REVIEWS (2013)
Statins: Perspectives in cancer therapeutics
Laurent Corcos et al.
DIGESTIVE AND LIVER DISEASE (2013)
Glutamine supports pancreatic cancer growth through a KRAS-regulated metabolic pathway
Jaekyoung Son et al.
NATURE (2013)
Transcriptome Analysis of Genes Regulated by Cholesterol Loading in Two Strains of Mouse Macrophages Associates Lysosome Pathway and ER Stress Response with Atherosclerosis Susceptibility
Stela Z. Berisha et al.
PLOS ONE (2013)
Strengthened glycolysis under hypoxia supports tumor symbiosis and hexosamine biosynthesis in pancreatic adenocarcinoma
Fabienne Guillaumond et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2013)
Statins and Protein Prenylation in Cancer Cell Biology and Therapy
Carmen Garcia-Ruiz et al.
ANTI-CANCER AGENTS IN MEDICINAL CHEMISTRY (2012)
Oncogenic Kras Maintains Pancreatic Tumors through Regulation of Anabolic Glucose Metabolism
Haoqiang Ying et al.
CELL (2012)
Cholesterol and prostate cancer
Kristine Pelton et al.
CURRENT OPINION IN PHARMACOLOGY (2012)
Pancreatic cancer: Overview of descriptive epidemiology
Cristina Bosetti et al.
MOLECULAR CARCINOGENESIS (2012)
Involvement of Chk1-Cdc25A-cyclin A/CDk2 pathway in simvastatin induced S-phase cell cycle arrest and apoptosis in multiple myeloma cells
Yong-Sheng Tu et al.
EUROPEAN JOURNAL OF PHARMACOLOGY (2011)
Lipid rafts: signaling and sorting platforms of cells and their roles in cancer
Simon Staubach et al.
EXPERT REVIEW OF PROTEOMICS (2011)
Cell cholesterol homeostasis: Mediation by active cholesterol
Theodore L. Steck et al.
TRENDS IN CELL BIOLOGY (2010)
Mitochondrial cholesterol contributes to chemotherapy resistance in hepatocellular carcinoma
Joan Montero et al.
CANCER RESEARCH (2008)
Cellular cholesterol trafficking and compartmentalization
Elina Ikonen
NATURE REVIEWS MOLECULAR CELL BIOLOGY (2008)
Cholesterol level of lipid raft microdomains regulates apoptotic cell death in prostate cancer cells through EGFR-mediated Akt and ERK signal transduction
Hea Young Oh et al.
PROSTATE (2007)
Pitavastatin-induced downregulation of CCR2 and CCR5 in monocytes is associated with arrest of cell-cycle in S phase
Masahiro Fujino et al.
ATHEROSCLEROSIS (2006)
Elevated levels of cholesterol-rich lipid rafts in cancer cells are correlated with apoptosis sensitivity induced by cholesterol-depleting agents
YC Li et al.
AMERICAN JOURNAL OF PATHOLOGY (2006)
Protein sensors for membrane sterols
JL Goldstein et al.
CELL (2006)
OSBP is a cholesterol-regrulated scaffolding protein in control of ERK1/2 activation
PY Wang et al.
SCIENCE (2005)
Activated Kras and Ink4a/Arf deficiency cooperate to produce metastatic pancreatic ductal adenocarcinoma
AJ Aguirre et al.
GENES & DEVELOPMENT (2003)
A cholesterol-regulated PP2A/HePTP complex with dual specificity ERK1/2 phosphatase activity
PY Wang et al.
EMBO JOURNAL (2003)
Consequences of cellular cholesterol accumulation: basic concepts and physiological implications
I Tabas
JOURNAL OF CLINICAL INVESTIGATION (2002)
Elevated uptake of low density lipoprotein by drug resistant human leukemic cell lines
L Tatidis et al.
BIOCHEMICAL PHARMACOLOGY (2002)
Share Paper
